Event Details

November 23, 2021

Description

Final pretrial conference U.S. v. Ghislaine Maxwell

Participants (4)

Name Type Mentions
Alison Nathan person 38 View Entity
Judge Alison Nathan person 2 View Entity
Counsel person 172 View Entity
GHISLAINE MAXWELL person 9575 View Entity

Source Documents (4)

EFTA00024892.pdf

Email / Press Guidance • 198 KB
View

This document is an email and attached press guidance from the US Attorney's Office (SDNY) regarding the trial of U.S. v. Ghislaine Maxwell in November 2021. It outlines the specific charges against Maxwell (Counts 1-6) and their maximum prison sentences, while also providing off-the-record guidance that certain witnesses will testify under pseudonyms to protect victim identities. The document includes logistical details for the press, such as the final pretrial conference schedule with Judge Alison Nathan and instructions for accessing government exhibits via the SDNY file share.

EFTA00016489.pdf

Email Chain / Press Guidance • 199 KB
View

This document is an email chain dated November 26, 2021, between Dipesh Gadher of The Sunday Times and Nicholas Biase of the U.S. Attorney's Office (SDNY). The correspondence concerns press guidance for the U.S. v. Ghislaine Maxwell trial, specifically addressing whether a certain witness (whose name is redacted) can be identified by the media. The email includes official 'Off-the-Record' press guidance detailing court logistics, the use of pseudonyms for victims, and access to government exhibits.

EFTA00031173.pdf

Email Chain / Press Guidance • 190 KB
View

This document is an email chain and press guidance from the U.S. Attorney's Office (SDNY) dated November 26, 2021, regarding the Ghislaine Maxwell trial. It details a specific interaction between journalist Dipesh Gadher of The Sunday Times and the SDNY press office concerning the identification of a victim/witness who had previously waived anonymity; the SDNY instructs that the court order requires the use of pseudonyms regardless of prior waivers. The document also includes general press guidance regarding trial logistics, the use of pseudonyms for sensitive witnesses, and access to government exhibits.

EFTA00029582.pdf

Email / Press Guidance • 121 KB
View

An email from the SDNY Attorney's Office providing press guidance for the U.S. v. Ghislaine Maxwell trial dated November 23, 2021. The document outlines privacy measures for victim witnesses testifying under pseudonyms, details the schedule for the final pretrial conference before Judge Alison Nathan, and provides instructions for media access to exhibits and credentialing.

Related Events

Events with shared participants

Notice of Appearance as Substitute Counsel filed on behalf of Appellant Ghislaine Maxwell

2021-03-30 • 02nd Circuit Court of Appeals

View

A shipment discussed in court, sent from Ghislaine Maxwell to Casey Wasserman. The event is stated to have occurred in 'October'.

Date unknown

View

LETTER REPLY TO RESPONSE to Motion filed by Ghislaine Maxwell.

2020-07-29

View

Filing or processing of the Reply Memorandum in Support of Third Motion for Bail

2021-04-01 • Federal Court (Implied)

View

Filing of Document 172-1 in Case 1:20-cr-00330-AJN

2021-03-23 • US District Court

View

Arraignment. Defendant entered plea of Not Guilty. Trial set for July 12, 2021.

2020-07-14 • Video Conference / Telephone

View

U.S. Attorney's Office contacted Epstein's counsel to negotiate a resolution (Non-Prosecution Agreement).

2007-01-01 • Southern District of Florida

View

Legal mail deposited in the MDC legal mailbox by counsel.

2021-10-02 • MDC Legal Mailbox

View

Questioning Ghislaine Maxwell about Reid Hoffman getting massages.

Date unknown

View

Filing of Public Access Findings as to Ghislaine Maxwell

2020-07-02 • U.S. District Court, District of New Hampshire

View

Event Metadata

Type
Unknown
Location
Courtroom 318, 40 Foley Square
Significance Score
5/10
Participants
4
Source Documents
4
Extracted
2025-12-26 00:02

Additional Data

Source
EFTA00031173.pdf
Date String
Upcoming (relative to doc)

Discussion 0

Sign in to join the discussion

No comments yet

Be the first to share your thoughts on this epstein event